Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Trial Identifier: D6930L00001
Sponsor: AstraZeneca
Collaborator:
Premier HealthCare Solutions Inc.
NCTID:: NCT06422689
Start Date: May 2024
Primary Completion Date: April 2026
Study Completion Date: April 2026
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, MA Springfield, MA, US, 01199
US, MI Flint, MI, US, 48532
US, MN Minneapolis, MN, US, 55425